Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia

Éric Jourdan, Nicolas Boissel, Sylvie Chevret, +22

Blood

Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenstrom's macroglobulinemia

Florence Nguyen‐Khac, Jérôme Lambert, Élise Chapiro, +26

Haematologica

Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K

Isabelle Luquet, Jia‐Qi Lai, Carole Barin, +25

Leukemia SocietyHematological MalignancyMedicineMixed-phenotype Acute LeukemiaHematology +7

NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis

Stéphanie Struski, Stéphanie Lagarde, Pierre Bories, +23

Leukemia

Genetic DisorderGeneticsPathologyPoor PrognosisMolecular Pathology +6

A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study

Patrice Chevallier, Myriam Labopin, Pascal Turlure, +17

Leukemia

Hematological MalignancyPrognostic EvaluationMedicineMixed-phenotype Acute LeukemiaPrognosis +8

Addition of Gemtuzumab Ozogamycin to Chemotherapy Improves Event-Free Survival but Not Overall Survival of AML Patients with Intermediate Cytogenetics Not Eligible for Allogeneic Transplantation. Results of the GOELAMS AML 2006 IR Study

Jacques Delaunay, Christian Récher, Arnaud Pigneux, +20

Blood

Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogénétique Hématologique study

Étienne Coyaud, Stéphanie Struski, Naïs Prade, +26

Blood

Improved outcome for AML patients over the years 2000–2014

Sarah Bertoli, Suzanne Tavitian, Anne Huynh, +10

Blood Cancer Journal

Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results

Nicole Dastugue, Stefan Suciu, Geneviève Plat, +22

Blood

Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study

Francis Lacombe, Christine Arnoulet, Marc Maynadié, +7

Leukemia

Hematological MalignancyHealth SciencesMedicineMixed-phenotype Acute LeukemiaMalignant Blood Disorder +10